The Scientist

» NIH, disease/medicine and evolution

Most Recent

image: PubMed-Indexed Abstracts to Include COI Statements

PubMed-Indexed Abstracts to Include COI Statements

By | April 19, 2017

Expressions of concern will also be linked in study summaries. 

0 Comments

image: New Giant Virus Group Reported

New Giant Virus Group Reported

By | April 6, 2017

A genomic analysis of “Klosneuviruses” suggests that they evolved from small viruses that accumulated genetic material over time, but not all virologists are convinced. 

0 Comments

image: Trump Meets with HHS, NIH Brass

Trump Meets with HHS, NIH Brass

By | April 5, 2017

President Donald Trump, HHS Secretary Tom Price, and NIH Director Francis Collins discussed the opioid crisis and retaining young researchers in the biomedical research enterprise, among other things, according to a White House official.

0 Comments

image: Image of the Day: Works In Progress

Image of the Day: Works In Progress

By | April 5, 2017

An NIH survey of 351 individuals in the research community has shown that many are supportive of interim research products like preprints.

0 Comments

Both Democrats and Republications criticize the Trump administration’s plan to cut funding for biomedical research.

0 Comments

image: The Invention Return on NIH Investments

The Invention Return on NIH Investments

By | April 2, 2017

Around 8 percent of grants funded by the National Institutes of Health resulted in patents.

0 Comments

image: Contributors

Contributors

By | April 1, 2017

Meet some of the people featured in the April 2017 issue of The Scientist.

0 Comments

image: Hitting It Out of the Park

Hitting It Out of the Park

By | April 1, 2017

Cancer can be as evasive and slippery as a spitball, but new immunotherapies are starting to connect.

0 Comments

image: Location, Location, Location

Location, Location, Location

By | April 1, 2017

Since first proposing that a cell’s function and biology depend on its surroundings, Mina Bissell continues to probe the role of the extracellular matrix.

2 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS